Veracyte to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
13 December 2023 - 8:30AM
Business Wire
Veracyte, Inc. (Nasdaq: VCYT) announced today that Marc Stapley,
chief executive officer, and Rebecca Chambers, chief financial
officer, will present at the 42nd annual J.P. Morgan Healthcare
Conference on Monday, January 8, 2024, at 1:30 p.m. Pacific
Time.
A live audio webcast of the company’s presentation will be
available by visiting Veracyte’s website at
http://investor.veracyte.com/events-presentations. A replay of the
webcast will be available for 30 days following the conclusion of
the live broadcast.
About Veracyte
Veracyte (Nasdaq: VCYT) is a global diagnostics company whose
vision is to transform cancer care for patients all over the world.
We empower clinicians with the high-value insights they need to
guide and assure patients at pivotal moments in the race to
diagnose and treat cancer. Our high-performing tests enable
clinicians to make more confident diagnostic, prognostic, and
treatment decisions for some of the most challenging diseases such
as thyroid, prostate, breast, bladder and lung cancers, as well as
interstitial lung diseases. We help patients avoid unnecessary
procedures and speed time to diagnosis and appropriate treatment.
In addition to making our tests available in the U.S. through our
central laboratories, we also aim to deliver our tests to patients
worldwide through a distributed model to laboratories that can
perform them locally. For more information, please visit
www.veracyte.com and follow the company on Twitter (@veracyte).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231212272032/en/
Investors: Shayla Gorman Sr. Director, Investor Relations
investors@veracyte.com 619-393-1545
Media: Tracy Morris Vice President of Global Corporate
Communications tracy.morris@veracyte.com 650-380-4413
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From May 2024 to Jun 2024
Veracyte (NASDAQ:VCYT)
Historical Stock Chart
From Jun 2023 to Jun 2024